Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease

被引:5
|
作者
Williams, Adam N. [1 ,2 ,3 ]
机构
[1] Bend Mem Clin, Dept Allergy Asthma & Immunol, 815 Southwest Bond St, Bend, OR 97702 USA
[2] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[3] Bend Mem Clin, 815 Southwest Bond St, Bend, OR 97702 USA
关键词
Aspirin-exacerbated respiratory disease; Diagnosis; NSAID hypersensitivity; Chronic rhinosinusitis with nasal polyps; Asthma; Intranasal ketorolac; Oral aspirin challenge; Lysine-aspirin; PERIPHERAL-BLOOD LEUKOCYTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEUKOTRIENE-MODIFIER DRUGS; NASAL PROVOCATION TEST; IN-VITRO DIAGNOSIS; INDUCED ASTHMA; SENSITIVE ASTHMATICS; BASOPHIL ACTIVATION; CYSTEINYL LEUKOTRIENES; LYSINE-ASPIRIN;
D O I
10.1016/j.iac.2016.06.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Aspirin-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). Distinguishing AERD from other forms of chronic sinusitis, asthma, and NSAID reactivity has important clinical implications for management. The clinical history is helpful, but not adequate for confirming the diagnosis of AERD, in most cases. Diagnostic provocation challenge remains the only way to confirm or exclude the diagnosis of AERD. This article discusses the utility of the clinical history and the current evidence regarding measures that optimize the safety of performing diagnostic NSAID provocation challenges.
引用
收藏
页码:657 / +
页数:14
相关论文
共 50 条
  • [21] Aspirin-exacerbated respiratory disease: aspirin desensitisation treatment
    Geraldo Dias, J.
    Costa, A.
    Caiado, J.
    Pedro, E.
    Pereira Barbosa, M.
    ALLERGY, 2010, 65 : 603 - 604
  • [22] Physiopathology and genetics in aspirin-exacerbated respiratory disease
    Pavon-Romero, Gandhi F.
    Ramirez-Jimenez, Fernando
    Alejandro Roldan-Alvarez, Marco
    Teran, Luis M.
    Falfan-Valencia, Ramces
    EXPERIMENTAL LUNG RESEARCH, 2017, 43 (08) : 327 - 335
  • [23] Upper airways in aspirin-exacerbated respiratory disease
    Choi, Jeong-Hee
    Kim, Ji-Hye
    Park, Hae-Sim
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 15 (01) : 21 - 26
  • [24] Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
    Dunn, Neha M.
    Katial, Rohit K.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (03) : 503 - +
  • [25] An update on the management of aspirin-exacerbated respiratory disease
    Lee, Ji-Ho
    Jung, Chang-Gyu
    Park, Hae-Sim
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (02) : 137 - 143
  • [26] Pathogenesis of Aspirin-Exacerbated Respiratory Disease and Reactions
    Laidlaw, Tanya M.
    Boyce, Joshua A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (02) : 195 - +
  • [27] Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease
    Stevenson, Donald D.
    White, Andrew A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (04) : 643 - +
  • [28] Platelets in patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    Boyce, Joshua A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (06) : 1407 - 1415
  • [29] Mast Cells in Aspirin-Exacerbated Respiratory Disease
    Edsel M. Abud
    Andrew A. White
    Current Allergy and Asthma Reports, 2024, 24 : 73 - 80
  • [30] PHENOTYPES/ENDOTYPES OF ASPIRIN-EXACERBATED RESPIRATORY DISEASE
    Park, Hae-Sim
    RESPIROLOGY, 2017, 22 : 7 - 7